Full Committee Business Meeting

The GOP Oversight Committee held a full committee business meeting on July 23, 2026, focusing on several legislative items with significant procurement and budget implications. Key discussions included the Pharmacists Fight Back Act (HR 6610), aimed at regulating pharmacy benefit managers (PBMs) to reduce prescription drug costs for federal employees by increasing transparency and limiting abusive practices; the DC Taxing Authority Review Act (HR 9720), which would require congressional approval for any new or increased taxes or fees imposed by the District of Columbia, sparking debate over local governance and fiscal responsibility; and the Restoring Integrity and Efficiency to Inspector General Oversight Act of 2025 (HR 9725), proposing to abolish the Council of Inspectors General on Integrity and Efficiency (CIGIE) due to concerns about politicization and inefficiency. The committee also considered the Comment Integrity and Management Act (HR 9643) to improve the management of electronic public comments in regulatory processes. Each bill was amended and favorably reported out of committee following recorded votes. The meeting included extensive debate on the impact of these bills on federal spending, oversight, and local governance, with bipartisan support and opposition expressed. Additionally, an en bloc package of postal naming bills was approved. The committee authorized members to file supplemental views and adjourned without further business.